$XRP $BTC This structure is uncanny š āthe only difference in this fractal is market positioning. The 2017 accumulation was during a bear market. The 2025 accumulation is during a bull market. Patiently waiting.
XRP Futures Hit Record Highs as CME Sees Explosive Q3 Growth Institutional appetite for regulated crypto assets, particularly XRP, is accelerating, propelling derivatives markets to record highs. CME Group published its Crypto Insights report for October 2025 last week, revealing that the third quarter of this year was its strongest on record, with combined crypto futures and options volume surpassing $900 billion and average daily open interest (OI) climbing to $31.3 billion. The report identified 1,014 large open interest holders (LOIH), underscoring the deepening role of institutional investors in the crypto sector and marking a pivotal stage in the evolution of digital asset markets.
CME Group stated: āQ3 demonstrated a surge in demand for regulated crypto exposure, with solana ( SOL) and XRP futures reaching all-time highs, signaling growing institutional and retail interest that extends beyond bitcoin and ether.ā The firm reported particularly strong performance in XRP derivatives, stating:
XRP: Since launch in May, the XRP and Micro XRP futures suite has traded 476K contracts, equating to over $23.7B in notional value. OI reached $1.4B in September and set a new LOIH record of 29 for XRP futures. #Xrpš„š„
#BNBATH #bnb Based on recent data, the all-time high (ATH) for BNB (Binance Coin) is approximately $1,087, which was reached on September 21, 2025. It's important to note that cryptocurrency prices are highly volatile and can change rapidly. Always refer to a live and reputable crypto-tracking website for the most current information.
Bionexus Gene Lab Corp Makes History With Ethereum-Focused Treasury Strategy
ļæ¼
ļæ¼
ByĀ Terence Zimwara
Fri Mar 7 1:30:45 EST 2025
Nasdaq-listed Bionexus Gene Lab Corp (BGLC) has approved a treasury strategy centered on ethereum.
Wyoming Blockchain Laws Hailed
Bionexus Gene Lab Corp (BGLC), a technology and healthcare-focused company incorporated in Wyoming, announced on March 6 that its board of directors has approved an ethereum-focused treasury strategy. This move makes the Nasdaq-listed company the first to āexclusively prioritize Ethereum (ETH) as a strategic treasury asset.ā
According to a pressĀ statement, BGLC has also released its Ethereum strategy whitepaper, which explains why the company chose the second-largest cryptocurrency. The statement adds that Wyomingās āforward-thinking blockchain lawsā were crucial in guiding BGLC in its current direction.
Commenting on the announcement, the companyās CEO, Sam Tan, said:
By integrating Ethereum into our corporate treasury, BioNexus Gene Lab Corp. is embracing the future of financial infrastructure. Ethereum offers high liquidity, utility, and stability compared to other digital assets, positioning BGLC as a leader in blockchain-integrated corporate finance. Wyomingās regulatory leadership further validates our decision, as it fosters an environment where blockchain businesses can thrive.
While other listed companies like Strategy (formerly Microstrategy) and Metaplanet have prioritized bitcoin (BTC), BGLC stated that an extensive analysis ofĀ ETHĀ prompted its board to opt for the latter. Factors that influenced the BGLC boardās decision include Ethereumās institut yield-generating capabilities.
Upcoming improvements to the protocol, such as the Pectra upgrade, as well as Ethereumās dominance in financial infrastructure, were also identified as reasons for choosingĀ ETH.
As part of this strategy, BGLC plans to expand its use of Ethereum and blockchain technology, focusing on financial applications, treasury management, and integrating blockchain into $ETH
Markets are ever-changingānew trends emerge, technologies evolve, and strategies shift. Yet, the old trader remains, shaped by experience, patience, and the wisdom of cycles. While the market thrives on volatility and innovation, the seasoned trader knows that discipline outlasts trends, and true success lies not in chasing the new, but in mastering the timeless principles of risk, strategy, and resilience.